EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitigating effect of naringenin on potassium bromate-induced nephrotoxicity in vivo

Iftekhar Hassan, Hossam Ebaid, Badar Ul Islam, Jameel Al-Tamimi, Zeinab Abdelftah, Shazia Aman, Ibrahim M Alhazza, Ezzat M Awad

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 15183-15197

DOI: 10.1007/s00210-026-05271-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 22.04.2026. Verfasst von Iftekhar Hassan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia. ihassan@ksu.edu.sa. Hauptthemen laut MEDLINE: Bromates, Flavanones, Kidney, Kidney Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ongoing Research Funding Program, King Saud University, Riyadh, Saudi Arabia, Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The usage of potassium bromate (PB) in various consumer items and food and chemical industries poses a serious health risk like nephrotoxicity along with other toxic abuses. The compound elicits mild to severe toxic insults in a dose-dependent way in vivo and can even trigger carcinogenesis if exposed for long. This investigation ascertains the protective effect of naringenin (NIR), a polyphenol, in the PB-challenged rats. The animals were categorized into five treatment groups: Group I (control), and Groups II and III were treated with PB alone (100 mg/kg) and NIR alone (20 mg/kg), respectively. The groups– IV and V were administered with NIR at 20 and 40 mg/kg in the PB-exposed rats. The animals were killed to get their kidney and blood samples for biochemical, molecular, and histological alaysis. The group II exhibited an enhanced level of renal function and toxicity markers in serum, validating nephrotoxicity. Further, dysregulated redox parameters (GSH and MDA) and suppressed antioxidant enzymes (SOD and CAT) consolidated the same. Group III showed negligible toxicity, with most of the parameters' values close to the control. Intriguingly, groups- IV and V bestowed remarkable alleviation in the PB-induced nephrotoxicity in a dose -dependent way. In addition, the comet assay and histological evaluation further confirmed these findings. The study concludes that NIR effectively protects against PB-induced nephrotoxicity in rats attributed by regulating oxidative stress and promoting structural restoration at both macromolecular and cellular levels. Therefore, NIR is a suitable candidate for use in consumer products containing PB or as a treatment to alleviate nephrotoxicity caused by PB or similar compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BromatesFlavanonesKidneyKidney DiseasesAntioxidantsAnimalsMaleRats, WistarOxidative StressDose-Response Relationship, DrugRatsSuperoxide DismutaseGlutathione

Stichwörter der Autor:innen

NaringeninNephrotoxicityPotassium bromateRatsStress

Substanzen

potassium bromateBromatesFlavanonesnaringeninAntioxidantsSuperoxide DismutaseGlutathione

Autor:innen und Institutionen

  • Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia. ihassan@ksu.edu.sa.
  • Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
  • Department of Biochemistry, Ram Gopal Medical College and Research Center, Hathras, India.
  • Comparative Anatomy and Embryology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, 62521, Egypt.
  • Department of Biochemistry, J N Medical College and Hospital, Aligarh Muslim University, Aligarh, 202002, India.
  • Center of Ocular Inflammation and Infection, Laura Bassi Centres of Expertise (OCUVAC), Institute of Specific Prophylaxis and Tropical Medicine [ISPTM], Center for Pathophysiology, Infectiology and Immunology [CePII], M…

Förderung

  • Ongoing Research Funding Program, King Saud University, Riyadh, Saudi Arabia
  • Medical University of Vienna

Zitieren

APA

Hassan, I., Ebaid, H., Islam, B. U., Al-Tamimi, J., Abdelftah, Z., Aman, S., Alhazza, I. M., & Awad, E. M. (2026). Mitigating effect of naringenin on potassium bromate-induced nephrotoxicity in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 15183-15197. https://doi.org/10.1007/s00210-026-05271-3

Vancouver

Hassan I, Ebaid H, Islam BU, Al-Tamimi J, Abdelftah Z, Aman S, et al. Mitigating effect of naringenin on potassium bromate-induced nephrotoxicity in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):15183-15197. doi:10.1007/s00210-026-05271-3

BibTeX
@article{Hassan2026,
  author = {Hassan, Iftekhar and Ebaid, Hossam and Islam, Badar Ul and Al-Tamimi, Jameel and Abdelftah, Zeinab and Aman, Shazia and Alhazza, Ibrahim M and Awad, Ezzat M},
  title = {Mitigating effect of naringenin on potassium bromate-induced nephrotoxicity in vivo},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {10},
  pages = {15183--15197},
  doi = {10.1007/s00210-026-05271-3}
}
Kostenlos starten →